Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

NCT01793948 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Obesity

Interventions

DRUG: metformin hydrochloride
OTHER: placebo
OTHER: laboratory biomarker analysis

Sponsor

Anna Maria Storniolo

Collaborators

[object Object]